<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Aborig M</submitter><funding>Telus Ride for Dad</funding><funding>Canadian Institutes of Health Research</funding><pagination>E179</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6523871</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>Gold nanoparticles (AuNPs) are a focus of growing medical research applications due to their unique chemical, electrical and optical properties. Because of uncertain toxicity, "green" synthesis methods are emerging, using plant extracts to improve biological and environmental compatibility. Here we explore the biodistribution of green AuNPs in mice and prepare a physiologically-based pharmacokinetic (PBPK) model to guide interspecies extrapolation. Monodisperse AuNPs were synthesized and capped with epigallocatechin gallate (EGCG) and curcumin. 64 CD-1 mice received the AuNPs by intraperitoneal injection. To assess biodistribution, groups of six mice were sacrificed at 1, 7, 14, 28 and 56 days, and their organs were analyzed for gold content using inductively coupled plasma mass spectromet</pubmed_abstract><journal>Pharmaceutics</journal><pubmed_title>Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation.</pubmed_title><pmcid>PMC6523871</pmcid><funding_grant_id>NA</funding_grant_id><pubmed_authors>Mutsaers A</pubmed_authors><pubmed_authors>Chelle P</pubmed_authors><pubmed_authors>Edginton AN</pubmed_authors><pubmed_authors>Darko J</pubmed_authors><pubmed_authors>Fleck A</pubmed_authors><pubmed_authors>Malik PRV</pubmed_authors><pubmed_authors>Nambiar S</pubmed_authors><pubmed_authors>Wettig S</pubmed_authors><pubmed_authors>Aborig M</pubmed_authors><pubmed_authors>Osei E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation.</name><description>Gold nanoparticles (AuNPs) are a focus of growing medical research applications due to their unique chemical, electrical and optical properties. Because of uncertain toxicity, "green" synthesis methods are emerging, using plant extracts to improve biological and environmental compatibility. Here we explore the biodistribution of green AuNPs in mice and prepare a physiologically-based pharmacokinetic (PBPK) model to guide interspecies extrapolation. Monodisperse AuNPs were synthesized and capped with epigallocatechin gallate (EGCG) and curcumin. 64 CD-1 mice received the AuNPs by intraperitoneal injection. To assess biodistribution, groups of six mice were sacrificed at 1, 7, 14, 28 and 56 days, and their organs were analyzed for gold content using inductively coupled plasma mass spectromet</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2025-04-05T12:40:59.367Z</modification><creation>2019-07-24T07:02:10Z</creation></dates><accession>S-EPMC6523871</accession><cross_references><pubmed>31013763</pubmed><doi>10.3390/pharmaceutics11040179</doi></cross_references></HashMap>